Search SEC
Fundamental Analysis
275 matches · 10756 cached companies
| Company | Fundamental | Momentum | Acceleration | Confidence | Revenue Growth | ROIC | FCF Growth | Op Margin Delta | Share Growth | Dividend Yield | Dividend Years | Payout Ratio | P/E | Signals |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AUPHAurinia Pharmaceuticals Inc. | 91 | 100 | 100 | 91 | +19.76% | +33.2% | n/a | +90.72% | -2.91% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage |
| ELTPELITE PHARMACEUTICALS INC /NV/ | 84.9 | 100 | 100 | 91 | +107.85% | +73.84% | n/a | +16.82% | +5.65% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction, Strong operating leverage1 warning |
| TBPHTheravance Biopharma, Inc. | 86.6 | 100 | 100 | 85 | +35.11% | n/a | n/a | +101.38% | +1.86% | 0% | 0 | n/a | 16.35x | Operating leverage, Net debt reduction |
| ROKROCKWELL AUTOMATION, INC | 73.5 | n/a | n/a | 100 | +9.21% | +25.87% | +105.97% | n/a | -1.5% | 1.21% | 45 | 44.99% | 37.34x | Gross margin expansion, FCF growth, Net debt reduction, Share count reduction |
| ANIPANI PHARMACEUTICALS INC | 83.5 | 93.6 | 96.2 | 83 | +51.82% | +16.93% | n/a | +35.17% | +9.32% | 0% | 0 | 1.48% | 17.7x | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction, Strong operating leverage1 warning |
| AMATAPPLIED MATERIALS INC /DE | 68.8 | 56.1 | 53.5 | 100 | +13.18% | +38.73% | +16.61% | -0.13% | -1.48% | 0.37% | 22 | 16.59% | 47.22x | Gross margin expansion, Operating leverage, FCF growth, Net debt reduction, Share count reduction, Strong operating leverage |
| MTSIMACOM Technology Solutions Holdings, Inc. | 67.8 | 87.4 | 90.4 | 100 | +39.86% | +15.8% | +40.8% | -3.22% | +3.52% | 0% | 0 | n/a | 108.53x | Gross margin expansion, Operating leverage, FCF growth, ROIC expansion, Net debt reduction, Strong operating leverage1 warning |
| ADMAADMA BIOLOGICS, INC. | 81.3 | 96.6 | 58 | 83 | +16.85% | +38.31% | n/a | +94.51% | -5.86% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, Share count reduction, Strong operating leverage4 warnings |
| PAHCPHIBRO ANIMAL HEALTH CORP | 66.2 | 89.9 | 93.9 | 100 | +57.45% | +15.31% | +217.22% | +3.73% | +0.79% | 1.29% | 13 | 19.68% | 15.45x | Gross margin expansion, Operating leverage, FCF growth, ROIC expansion, Net debt reduction, Strong operating leverage |
| MZTIMARZETTI CO | 65.9 | 49.9 | 51.2 | 100 | -0.55% | +19.87% | -17.07% | +4.7% | -0.43% | 4.02% | 41 | 56.76% | n/a | Gross margin expansion, ROIC expansion, Net debt reduction, Share count reduction1 warning |
| PSMTPRICESMART INC | 64.4 | 49.9 | 48.3 | 100 | +10.39% | +18.01% | -21.99% | +0.68% | +0.67% | 0.82% | 20 | 26.19% | 31.48x | Net debt reduction2 warnings |
| MODMODINE MANUFACTURING CO | 76.6 | 50.5 | 42.9 | 83 | +28.78% | +23.43% | n/a | +4.29% | +0.19% | 0% | 0 | n/a | 78.81x | Gross margin expansion, Operating leverage, Net debt reduction, Strong operating leverage4 warnings |
| MSGEMadison Square Garden Entertainment Corp. | 74.5 | 85.5 | 91.3 | 85 | +5.38% | +34.52% | n/a | n/a | -0.99% | 0% | 0 | n/a | 45.65x | Operating leverage, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage |
| ACADACADIA PHARMACEUTICALS INC | 70.4 | 44 | 44 | 89 | +18.75% | +30.37% | n/a | n/a | +3.09% | 0% | 0 | n/a | 25.82x | Gross margin expansion, Net debt reduction1 warning |
| MRVLMarvell Technology, Inc. | 66.7 | 100 | 98.3 | 91 | +58.04% | +6.16% | n/a | +19.31% | +5.21% | 0.09% | 15 | 7.68% | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction1 warning |
| MGNIMAGNITE, INC. | 66.5 | 100 | 91.8 | 91 | +12.71% | +6.57% | n/a | +38.79% | +3.75% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction, Strong operating leverage |
| AGIOAGIOS PHARMACEUTICALS, INC. | 66.8 | 100 | 86 | 90 | +163.31% | -69.2% | n/a | +5,431.19% | +3.53% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, ROIC expansion |
| ADPAUTOMATIC DATA PROCESSING INC | 69.4 | n/a | n/a | 86 | +16.52% | n/a | n/a | n/a | -1.59% | 2.64% | 44 | 54.89% | 22.14x | Gross margin expansion, Net debt reduction, Share count reduction |
| CARTMaplebear Inc. | 71.1 | 63.1 | 69.3 | 83 | +15.42% | +21.23% | n/a | n/a | -10.19% | 0% | 0 | n/a | n/a | Operating leverage, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage1 warning |
| RIGLRIGEL PHARMACEUTICALS INC | 76.4 | 100 | 100 | 77 | +76.37% | +60.89% | n/a | +124.4% | +7.71% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, Net debt reduction, Strong operating leverage2 warnings |
| KNSAKiniksa Pharmaceuticals International, plc | 78.3 | 100 | 100 | 74 | +87.55% | +33.9% | n/a | n/a | +14.89% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction2 warnings |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 63.7 | 100 | 100 | 91 | +13.64% | +33.82% | n/a | -1% | -1.66% | 0% | 0 | n/a | 30.33x | Operating leverage, ROIC expansion, Net debt reduction, Share count reduction |
| IMAXIMAX CORP | 67.8 | 73.1 | 73.1 | 85 | +10.5% | +30.57% | n/a | +49.58% | +2.91% | 0% | 0 | n/a | 57.86x | Gross margin expansion, Operating leverage, Net debt reduction, Strong operating leverage |
| ABUSArbutus Biopharma Corp | 62.9 | 100 | 100 | 91 | +2,909.09% | +145.09% | n/a | +272.61% | +3.55% | 0% | 0 | n/a | n/a | Operating leverage, Net debt reduction |
| FEMYFEMASYS INC | 62.9 | 100 | 100 | 91 | +11.54% | -3,473.47% | n/a | +111.47% | -86.65% | 0% | 0 | n/a | n/a | Operating leverage, Share count reduction2 warnings |
1-25 of 275